chrisvoncsefalvay/vaers-outcomes huggingface dataset:
5/16/01 woke up with low grade fever. Ran fever every day and on 5/19/01 temp went up to 103.7. Mom called ER & ER nurse suggested she report this fever to vaccine administrator since she was the fourth person to report high fever after Prevnar vaccine. Child recovered by 5/20/01, no fever.
In the morning after the vaccine I was experiencing the regular sweats and chills. I also was experiencing back, neck, and hand pain throughout my upper torso. Three days later the hand pain stayed and it felt very arthritic pain, I could not make a fist with my right hand. I have never experienced pain as such before in my hands. On the same day my left eye felt very heavy and itchy like allergy symptoms. On the 14th of August my vision went completely blurry in my left eye, and has been blurry since that day. My PCP believes that I could possibly have had a CSR flare up that I have already experienced previously before the vaccine. The opthamologist decided to do a CSR scan and it came back negative but there was a possibility that it could have resolved it on its own.
Mildly pruritic macular rash on left shoulder (vacc. admin. site) 3-5 days after vaccine administration. Rash then spread to chest, upper back, Rt. upper shoulder.
Due to use of Benadryl, Allegra, and ibuprofen for the first few days, no symptoms noticed, however on discontinuation of these medications, pt had facial swelling, severe diffuse rash, swelling in the hands, and minor difficulty breathing.  This required treatment with antihistamines and corticosteroids to resolve.
48-72 hours post: sore arm, headache, extreme fatigue, felt feverish with no fever.  10 days post: developed sore muscle with warm, raised, very itchy, red rash on L arm from posterior above deltoid injection site to lower anterior bicep, approx  7 in. long, 2.5 in. wide.
Vaccine went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 07-MAR-2022; Patient received vaccine past its 30 days expiry date; Patient received 0.3 ml of booster dose; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30 days expiry date), INCORRECT DOSE ADMINISTERED (Patient received 0.3 ml of booster dose) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 07-MAR-2022) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     Acute illness at the time of vaccination and up to one month before was reported as unknown. Chronic or long-standing health conditions was reported as unknown.     On 07-Mar-2022 at 2:39 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .3 milliliter. On 07-Mar-2022 at 2:39 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30 days expiry date) and INCORRECT DOSE ADMINISTERED (Patient received 0.3 ml of booster dose). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 07-MAR-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30 days expiry date), INCORRECT DOSE ADMINISTERED (Patient received 0.3 ml of booster dose) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 07-MAR-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient ethnicity reported. Prescriptions, over the counter medications, dietary supplements or herbal remedies being taken at time of vaccination  or at the time of the adverse event were reported as unknown. Other vaccines given on the same day as Moderna COVID-19 vaccine and other vaccines received within one month prior to any dose of Moderna COVID-19 vaccine were reported as unknown. Patient received booster dose on 07-Mar-2022 at 02:39:06 PM.  No treatment information was reported.
No additional adverse effect reported.; temperature excursion / temperature 8.5 C; This spontaneous report was received from a registered medical assistant and refers to a patient of unknown age and gender. There was no information regarding their medical history, concurrent conditions nor concomitant therapies provided.  On 17-JUN-2021, the patient was vaccinated with an improperly stored dose of hepatitis A vaccine, inactivated (VAQTA) lot # and expiration date were reported as T023919 and 31-MAR-2022, respectively (exact dose, route of administration and anatomical location were not provided) for prophylaxis. The administered dose of the vaccine was stored in a temperature of 8.5 degrees Celsius (C) for 50 minutes. There was no previous temperature excursion reported. Digital data logger was involved. No adverse effect was reported.  Lot # T023919 is an invalid lot number for hepatitis A vaccine, inactivated (VAQTA).
Within 4 hr of receiving pneumococcal/influenza vaccine, patient had hives on arms bilaterally. Itchy sensation behind ears. Noticed she had to use her O2 more frequently than usual usage.
2 episodes of eyes rolling upward & crossing about 1 hr apart; 1st 1 lasted 10mins, 2nd 5 mins on 28OCt92 @ 630PM; 730PM seen @ 2 ER's-found nl;
Information has been received from a physician concerning a 14 year old male who on 14-MAY-1996 and 08-FEB-1999 was vaccinated with the first and second doses of MMR II (Lot # not reported), respectively.  On 11-NOV-2009 the patient experienced onset of symptoms.  On 13-NOV-2009, the patient was diagnosed with mumps.  The patient was afebrile and had parotitis of right.  On 13-NOV-2009, the patient had blood work done that revealed IgM was negative, IgG was 3.56 and serum amylase was 89.  At the time of the report, the patient's outcome was unknown.  Additional information has been requested.
Patient states the evening of receiving the PNEUMOVAX vaccine she experienced Rt arm pain, stiffness, swelling, fever with chills, lightheaded, fatigue. PNEUMOVAX given 10/14/13 at 9:30 am.
Information has been received from an office manager concerning a patient who on 28-JUN-2010 was vaccinated with a dose of VARIVAX (Merck) IM instead of SC. No adverse effects were reported. Follow-up information received from an office manager concerning a 12 year old male patient with no illness at time of vaccination, no preexisting allergies, birth defects and medical conditions, and no adverse event following prior vaccinations, who on 28-JUN-2010 at 11:30 am was vaccinated with the second dose of VARIVAX (Merck) (lot # 665575/1229Y, in the left deltoid) IM instead of SC. Concomitant therapy included the first dose of MENACTRA (unspecified, sanofi, lot # U3465AA, IM ) in the right deltoid and the sixth dose of BOOSTRIX (lot # AC52B061EA, IM) in the left deltoid on 28-JUN-2010 at 11:30 am. It was reported that the patient did develop rash on 23-AUG-2010, diagnosed as 704.8. The patient's brother had rash 2 days earlier, and both in hot tub during previous week. The event was described as macro papular rash on torso, upper arms and slightly on the upper legs. There were no labs or diagnostic tests performed. At time of report, the patient recovered. Additional information is not expected. The patient's brother information has been captured in WAES # 1009USA05027.
noticed rash/hive/red patches on upper left arm, about 2 inches away from the injection site, about 3 inches in diameter at 7 am on 4/10/21, not itchy, slight muscle ache in the injection area when the arm is moving.  no treatment. about ~ 90% resolved at 10 pm on 4/11/2021.
Severe pain bilateral shoulder after receiving both the Fluzone and Prevenar vaccines., inability to move either arm above head without using opposite arm to lift, difficulty getting dressed, Pain started on the 11/3 and became progressively worse by 11/5. Pain not relieved with Advil and had to take 2 Advil and 2 tylenol to get any pain relief and be able to sleep. Loss full ROM in both arms, limited ability to lift anything,
Headache, Myalgia, Arthralgia, malaise, "Brain Fog" Narrative:
First am following injection quarter size swelling red warm welt. second am following injection painful swollen 3 inch diameter warm welt. possible fever-did not take but felt groggy and warm.  3rd day receding-expect to resolve soon.
Headache, joint ache, heart arrhythmia, breathlessness. Major issues until 2/7/2021. Still have intermittent headaches and heart flutter that wasn't there before.
Extreme pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 78 year-old female patient received bnt162b2 (BNT162B2), administered in arm, administration date 24Mar2021 04:00 (Lot number: EP6955) at the age of 78 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Spinal stenosis" (unspecified if ongoing); "Smoldering multiple myeloma" (unspecified if ongoing). Concomitant medication(s) included: IBUPROFEN; PREDNISONE; TRIAMTERENE HCTZ; METOPROLOL; ZOLPIDEM; OXYCODONE; LISINOPRIL; ATORVASTATIN; CALCIUM; FLUTICASONE PROPIONATE. Vaccination history included: Bnt162b2 (1st dose, lot number=EN6204), for Covid-19 immunisation. The following information was reported: PAIN (non-serious) with onset 26Mar2021, outcome "not recovered", described as "Extreme pain". Therapeutic measures were not taken as a result of pain.  Additional information: Patient was also taking unspecified vitamins as concomitant medication. It was reported that patient had been in extreme pain since Friday, when he had the Pfizer vaccine (Covid Vaccine) at 4 o' clock Wednesday and he was wondering if it would be because of the vaccine. He had never been in this kind of pain. He also stated that he was in bed and can barely move out of it. He just wanted to know if this could be due to the vaccine.  No follow-up attempts are possible. No further information is expected.
Rash on same arm as shot and a little swelling.  The end of June same thing on same arm and on the side.looked like bites. Both disappeared in a week.
"Swollen, red and warm" left upper thigh-per patient's mother. Cold compress on affected thigh-per mother.
second dose >36 days after; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose >36 days after) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006C21A and 032821A) for COVID-19 vaccination.     The patient's past medical history included Multiple sclerosis.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Sep-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose >36 days after). On 29-Sep-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose >36 days after) had resolved.            No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-336457 (Patient Link).
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 10Nov2021 as dose 3 (booster), single (Lot number: 330268D) at the age of 43 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Rispiradone" (unspecified if ongoing). Concomitant medication(s) included: ABILIFY; LAMOTRIGINE; CLONOPIN; FLEXERIL [CEFIXIME]. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Rebound Covid positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical courses: Adverse event: Rebound Covid positive post Paxlovid treatment on 06Jul2022 at 20:00. No treatment was received for the rebound. Other medication in 2 weeks product included Abilify, Lamotrigine, Klonopin, Flexeril
Hives on the chest; Swollen and sore left armpit; Swollen and sore left armpit; Right butt cheek was sore; Chills; Headache/the next day headache/ a severe and sudden headache; Soreness in arm; Swelling and pain in the inner labia; swelling and pain in the inner labia; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 05May2021 at 12:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included covid-19, and mild seasonal allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient received hpv vaccine (MANUFACTURER UNKNOWN) on 21Apr2021 within four weeks prior to the vaccination. On 05May2021 at 22:00 the patient started feeling a headache, soreness in arm and swelling and pain in the inner labia in the evening, the next day(06May2021), right butt cheek was sore and swollen, headache and chills. On 07May2021, she developed a severe and sudden headache, hives on the chest, soreness and pain in the inner labia and swollen and sore left armpit. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, soreness in arm and swelling and pain in the inner labia, right butt cheek was sore and swollen, chills, severe and sudden headache, hives on the chest and swollen and sore left armpit were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Patient complains of difficulty with range of motion in his shoulder.  He cannot reach backward fully with his arm.  Reported upon arrival for 2nd dose.  Recommendation to contact doctor if not improved soon in case he needs physical therapy exercises.
Fever and Chills of 102F for approx. 36 hours.  Arm pain at injection site for approx 48 hours.  Headache for approx. 72 hours.  Fatigue for approx. 72 hours  Rest and Tylenol for treatment
weakness; diarrhea; was not coherent/ mindlessness; nausea; reflexes were abnormal; lethargic; This spontaneous case was reported by a patient and describes the occurrence of ASTHENIA (weakness), DIARRHOEA (diarrhea), CONFUSIONAL STATE (was not coherent/ mindlessness), NAUSEA (nausea) and REFLEXES ABNORMAL (reflexes were abnormal) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Narcolepsy and COVID-19.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (weakness), DIARRHOEA (diarrhea), CONFUSIONAL STATE (was not coherent/ mindlessness), NAUSEA (nausea), REFLEXES ABNORMAL (reflexes were abnormal) and LETHARGY (lethargic). At the time of the report, ASTHENIA (weakness), DIARRHOEA (diarrhea), CONFUSIONAL STATE (was not coherent/ mindlessness), NAUSEA (nausea), REFLEXES ABNORMAL (reflexes were abnormal) and LETHARGY (lethargic) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.
Patient felt faint nearly immediately after but said she wasn't having problems breathing.   She was told to breath deeply and she quickly started feeling "a little better" so she was helped to a chair with arm rests in the room.  She said she had an orange in her bag, so she started eating her orange.  Just a minute later she said she was going to pass out, so the pharmacist caught her.  He held her up in the chair and tried to revive her for a few moments but noticed that the blood was draining from her face and her lips were turning blue so yelled for one of his technicians to call 911 and the other to grab an epi pen.  He then lowered her to the floor in case he needed to begin to resuscitate while the technician brought him the epipen.  While lowering her she urinated on herself.  As the pharmacist went to check her vitals before administering the epipen and beginning cpr if necessary the patient suddenly gasped once and her eyes opened widely, but not continue to breath.  Upon inspection in her mouth there was a piece of orange near the bottom of the throat.  The pharmacist asked if she was choking and she did not response at all, but did not start visibly breathing either.  So the pharmacist swiped the piece of orange out quickly, in case it was either previously lodged or patient would have to be resuscitated.  She did not seem to enjoy this and this seemed to wake her up and she quietly gasped not choking.  She started to quickly improve and admitted that she was feeling better, and had passed out before after getting blood drawn but never after a shot so didn't mention this.  While this was happening a police office was going through the drive through so the technician called him in for assistance and he arrived around this time.  He asked her a few questions like "what's her name, who's president, how many quarters are in a dollar" which she was able to answer.  She said she was mostly embarrassed and was feeling much better.  She sat up in the chair again about the time the emts came in.  The checked her out, but she didn't want to go to the Emergency Room.  She was driven home by her father.  I called her later around 6 pm that night and she said she was feeling totally fine and I advised her to please call her PCP and discuss this incident with him or her.
Information has been received from a healthcare worker referring to unspecified patients of unknown age and gender. There was no medical history or concurrent condition reported. On an unknown date the unspecified patients were vaccinated with improperly stored PNEUMOVAX 23 (dosage, strength, lot # and route were not reported). There was no concomitant medication reported. At the time of the report, no adverse event was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a pharmacist (Pharm.D.) concerning a patient who on an unknown date, was vaccinated with a dose of PNEUMOVAX 23 (dose, route and lot# not reported). Subsequently the patient experienced urticaria. It was unknown if the patient sought medical attention. At the time of reporting, the outcome was unknown. Additional information has been requested.
On 7-18-2011 at night rash on foot. New lesions continue to break out. Itchy, no fever, no associated illness symptoms. On 7-20-11 some of lesions are scabbing. New lesion in mouth developed.
Information has been received from a health professional concerning a 21 year old female patient with psoriasis and Raynaud's syndrome who on an unspecified date was vaccinated I.M. with a dose of GARDASIL (dose unknown). The health professional reported that the patient experienced "nausea and flare-ups of psoriasis and Raynaud's disease after receiving GARDASIL". The patient sought medical attention via an office visit. The outcome was not specified. Follow up information was received from the nurse who reported that the female patient with flare ups of psoriasis once or twice per year was vaccinated at another facility and the events were reported to her by the patient and not by direct observation. On the day the patient was vaccinated with the first dose of GARDASIL the patient experienced nausea, dizziness, was pale, and felt ill. A few days after receiving the injection the patient had itching. A few weeks after the injection the patient developed a flare up of psoriasis, this was more intense and prolonged than previous flare ups. The nurse also stated the patient has had more problems in the past year than before. On an unknown date, the patient recovered. It was unknown if the patient had any illnesses at the time of vaccination. There were no labs or diagnostic studies performed. No further information is available.
Info has been received from a health professional concerning a 10 year old white female, with no medical history and no allergies who on 1/12/96 was vaccinated with a 1st dose of varicella virus vaccine live. There was no illness at the time of vaccination and no adverse events following prior vaccination. It was reported that on 5/1/05, the pt experienced chickenpox breakthrough, during a middle school outbreak, described as a mild generalized rash with no fever. It was reported that the pt recovered with no hospitalization. Unspecified medical attention was sought. No produce quality complaint was involved. No other info was provided. Addition info is not expected.
RESIDENT WAS INADVERTENTLY ADMINISTERED HER BOOSTER DOSE OF PFIZER, BUT HAD PREVIOUSLY RECEIVED HER 3RD DOSE (IMMUNOCOMPROMISED). DATES OF PFIZER ADMINISTRATION: 1/12/21, 2/2/21, 8/26/21, 10/6/21.
It felt like covid, which I have had once. Chills, ache, headache, nausea, could not get out of bed. The injection site was very swollen and painful. It lasted exactly 24 hours. Then I was fine after that.
On 1/24/2022, I began having a fever. The fever ended up lasting for 4 days. At its highest point, it was 102 degrees, though it progressively declined over the following 3 days. I first took a PCR test on 1/24/2022, and the result was negative. I took another PCR test on 1/27/2022, and the result was positive. I got another positive result when I took a PCR test on 1/31/2022 and finally got a negative result when I took a PCR test on 2/3/2022. By 1/28/2022, the fever was gone, but I still had a cough. On 1/28/2022, my husband and I had a virtual conference with his doctor, who works in the same practice as my doctor, and we were just told to tell him if the cough worsened. It didn't worsen, but it did linger until March 2022. Until 2/23/2022, I was also very fatigued. I also experienced slowed mental function from the outset of the illness until 2/11/2022. Altogether, I wasn't able to do much for about a month. I was fully vaccinated (but without the booster), so this was a breakthrough case.